Back to top
more

KraneShares MSCI All China Health Care Index ETF: (KURE)

(Delayed Data from NYSE) As of Sep 13, 2024 03:59 PM ET

$13.20 USD

13.2
27,809

-0.05 (-0.38%)

Volume: 27,809

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $13.26 +0.06 (0.45 %) 7:58 PM ET

Zacks News

Yashwardhan Jain headshot

ETFs to Tap China's Economic Resurgence in 2024

With promising economic data and optimistic growth projections, the Chinese economy stands poised for a potential resurgence in 2024. Explore ETFs to leverage and capitalize on China's anticipated economic revival.

Sanghamitra Saha headshot

Time to Buy These China ETFs on Surprise Monetary Easing?

China's central bank surprised the market by announcing its second key policy rate cut in three months on Aug 17, 2023.

Yashwardhan Jain headshot

Country Garden Crisis Puts China ETFs in the Spotlight

Amidst China's ongoing real estate turmoil, the challenges faced by Country Garden hinder the sector's recovery efforts. Explore ETFs to navigate this uncertain terrain in the world's second-largest economy

Sanghamitra Saha headshot

Top-Performing ETF Areas of Last Week

Wall Street recorded a moderate performance last week. But the final week of the year was not that bad. This was probably because of the muted Santa Clause rally.

Sanghamitra Saha headshot

China ETFs Rallying: Top Gainers Past Month

China ETFs have been rallying of late to reflect easing Covid controls and a sweeping rescue package to bail out developers.

Sanghamitra Saha headshot

5 Top-Performing ETFs of Last Week

Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.

Sanghamitra Saha headshot

Best-Performing ETF Areas of Last Week

Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.

Sanghamitra Saha headshot

Top ETF Areas of Last Week

The markets rallied because Biden started his term by signing a number of executive orders to counter the ill effects of the COVID-19 pandemic, empower environmental protection initiatives and roll back many of the Trump administration's immigration policies.

Sanghamitra Saha headshot

5 Reasons to Bet on China ETFs

The Chinese economy returned to growth in the second quarter of 2020. This along with PBOC's targeted policy easing and China's solid tech industry make China investing winners in the recent trading sessions.

Sanghamitra Saha headshot

6 China ETFs From 3 Sectors That Emerged Winners in June

A host of China ETFs outperformed in June. These funds come mainly from the technology, healthcare and clean energy segments.

Sweta Killa headshot

3 Best Country ETFs of 1H That Survived the Pandemic

While most the countries' stocks have been beaten down badly in the pandemic, some still managed to trade in green for the first half of the year.

Sanghamitra Saha headshot

China Healthcare ETF (KURE) Hits New 52-Week High

The fund hit a 52-week high lately. Can this go further higher?

Sanghamitra Saha headshot

6 Equity ETFs in Green Last Week Despite Wall Street Bloodbath

Overall, the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 added 4.8%, 5.6%, 1.6%, and 7.9% last week, respectively.

Sanghamitra Saha headshot

China Healthcare ETF (KURE) Hits New 52-Week High

The fund KURE hit a 52-week high on May 14. Can it sustain the rally?

Sanghamitra Saha headshot

These China ETFs Hardly Felt Any Coronavirus Pain in Q1

Despite being the epicenter of the coronavirus, China ETFs held up pretty well in the first quarter.

Sanghamitra Saha headshot

5 International Equity ETFs That Topped S&P 500 in Q1

These international ETFs have outperformed the S&P 500 in the first quarter.

Sanghamitra Saha headshot

Wall Street in Correction: 4 Sector ETFs Unscathed in February

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

Sanghamitra Saha headshot

What Lies in China ETFs' Fortunes in the Year of Rat?

China ETFs delivered decent performance in the year of the pig. What would the year of the rat bring?

    Sanghamitra Saha headshot

    Don't Fear China's Weaker Growth, Play It With These ETFs

    Many investors may be worrying about slowing growth of the Chinese economy. But government efforts and trade optimism bode well for ETFs.

    Sanghamitra Saha headshot

    Stimulus Hopes Boost China's Stocks: ETFs Gain the Most

    China's stocks surge maximum in more than two years on hopes of authorities' support. Is it time to buy these ETFs?

    Sanghamitra Saha headshot

    Top and FLOP ETFs of Last Week

    Inside the top and worst-performing ETFs of last week.

      Sanghamitra Saha headshot

      Explore China's Booming Biopharma Space With This New ETF

      Inside the new China bio-pharma ETF and its possibilities.